Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"

NCT04204252 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Alpha 1-Antitrypsin Deficiency

Interventions

DRUG: Alpha 1-Antitrypsin
DRUG: Placebo

Sponsor

Kamada, Ltd.

Collaborators

[object Object]